The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Assessment of immune and clinical efficacy after intralesional PV-10 in injected and uninjected metastatic melanoma lesions.
Amod Sarnaik
Research Funding - Provectus Pharmaceuticals
Georgina Crago
Research Funding - Provectus Pharmaceuticals
Hao Liu
No relevant relationships to disclose
Krithika Nandakumar Kodumudi
No relevant relationships to disclose
Amy Weber
No relevant relationships to disclose
Timothy McCardle
No relevant relationships to disclose
Jeffrey S. Weber
No relevant relationships to disclose
Shari Pilon-Thomas
Research Funding - Provectus Pharmaceuticals